Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2019	2,678,909	69,661,436
Beginning balance, amount at Dec. 31, 2019	$ 26,788	$ 696,614	$ 37,107,730	$ (29,363,990)	$ 8,467,142
Common stock issued upon exercise of warrants, shares		250,000
Common stock issued upon exercise of warrants, amount		$ 2,500	60,000		62,500
Net loss				(308,882)	(308,882)
Ending balance, shares at Mar. 31, 2020	2,678,909	69,911,436
Ending balance, amount at Mar. 31, 2020	$ 26,788	$ 699,114	37,167,730	(29,672,872)	8,220,760
Beginning balance, shares at Dec. 31, 2020	2,678,909	75,949,757
Beginning balance, amount at Dec. 31, 2020	$ 26,788	$ 759,496	39,050,899	(32,650,794)	7,186,389
Issuance of common stock for cash, shares		26,290,000
Issuance of common stock for cash, amount		$ 262,900	24,734,100		24,997,000
Common stock issuance costs			(1,654,820)		(1,654,820)
Common stock issued upon exercise of warrants, shares		3,723,810
Common stock issued upon exercise of warrants, amount		$ 37,238	1,726,381		1,763,619
Net loss				(335,488)	(335,488)
Ending balance, shares at Mar. 31, 2021	2,678,909	105,963,567
Ending balance, amount at Mar. 31, 2021	$ 26,788	$ 1,059,634	$ 63,856,560	$ (32,986,282)	$ 31,956,700